Tempus AI (TEM) announced the company is scheduled to exhibit 4 abstracts at the American College of Cardiology, ACC, Annual Meeting, which ...

Tempus AI stock surged 40% YTD, driven by acquisitions and investor confidence in healthcare AI. Can its momentum spark ...

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free ...

Tempus AI leverages AI for treatment decisions and diagnostics, thriving in the booming healthcare AI market with strong ...

“We saw a paradigm shift in healthcare ... surrounded by a neural network of artificial intelligence code. Tempus AI ...

Tempus AI dropped its share prices for a second straight day on Wednesday, losing 9.08 percent to finish at $53.25 ahead of the Annual Needham Virtual Healthcare Conference from April 7 to 10, 2025.

Artificial Intelligence (AI)-based healthcare solutions company Tempus AI TEM has continued to capture investors’ attention despite reporting weaker-than-expected fourth-quarter 2024 results on ...

But one ticker that may be less recognizable among the AI crowd is certainly off to a roaring start since the ball fell on New Year's Eve. Skyrocketing 108% since the start of 2025, Tempus AI ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has acquired Deep 6 AI ...

Shares of Tempus AI (NASDAQ:TEM) dropped 19% Tuesday, the day after the AI-focused healthcare company released a Q4 earnings report that missed Street estimates and its 2025 financial forecast.

BofA raised the firm’s price target on Tempus AI (TEM) to $60 from $54 and keeps a Neutral rating on the shares after the company reported Q4 results on February 24 in-line with their mid-Jan ...

Financial giants have made a conspicuous bullish move on Tempus AI. Our analysis of options history for Tempus AI (NASDAQ:TEM) revealed 11 unusual trades. Delving into the details, we found 45% of ...